Degeneration of pyramidal projection neurons in Huntington's disease cortex

M Cudkowicz, NW Kowall - … of Neurology: Official Journal of the …, 1990 - Wiley Online Library
Annals of Neurology: Official Journal of the American Neurological …, 1990Wiley Online Library
We examined the distribution of neuropeptide Y immunoreactive local circuit neurons and
nonphosphorylated neurofilament (SMI 32) immunoreactive pyramidal projection neurons in
superior frontal cortex of patients with Huntington's disease and age‐matched control
subjects to determine the histological counterpart of increased neuropeptide Y and
decreased glutamate concentrations previously found in the cortex of patients with
Huntington's disease. We found no difference between the relative density of neuropeptide …
Abstract
We examined the distribution of neuropeptide Y immunoreactive local circuit neurons and nonphosphorylated neurofilament (SMI 32) immunoreactive pyramidal projection neurons in superior frontal cortex of patients with Huntington's disease and age‐matched control subjects to determine the histological counterpart of increased neuropeptide Y and decreased glutamate concentrations previously found in the cortex of patients with Huntington's disease. We found no difference between the relative density of neuropeptide Y neurons in Huntingon's disease and control brains in regions where the relative density of SMI 32 immunoreactive neurons was significantly reduced. Animal studies show that cortical local circuit neurons are resistant to N‐methyl‐D‐aspartate‐type excitotoxins such as quinolinic acid. Relative sparing of neuropeptide Y neurons in cerebral cortex with Huntington's disease may, therefore, be a result of excessive N‐methyl‐D‐asparate receptor activation.
Wiley Online Library